| Financial Year |
March 31 2023 |
| Monetary Funds |
149,426,097.15 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,566,000.00 |
| Accounts Receivable |
80,211,242.86 |
| Advances to Suppliers |
24,216,404.33 |
| Other Receivables |
1,419,786.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
154,173,185.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,932,191.47 |
| Total Current Assets |
441,189,482.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
411,206,024.40 |
| Under-construction Projects |
77,689,935.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
21,630,778.35 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,042,677.77 |
| Deferred Income Tax Assets |
89,366,062.47 |
| Other Non-Current Assets |
70,841,732.68 |
| Sub-Total of Non-Current Assets |
705,384,362.16 |
| Total Assets |
1,146,573,844.84 |
| Short-Term Loans |
50,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
132,841,820.07 |
| Accounts Received In Advance |
3,104,154.10 |
| Employee Compensation Payable |
3,108,948.03 |
| Taxes Payable |
25,937,378.37 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
76,064,960.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
62,234,236.36 |
| Other Current Liabilities |
27,842.18 |
| Sub-Total of Current Liabilities |
353,533,510.30 |
| Long-term Loans |
350,070,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,200,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,088,111.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
376,866,458.48 |
| Total Liabilities |
730,399,968.78 |
| Paid-In Capital(Or Share Stock) |
514,402,025.00 |
| Capital Surplus |
578,129,026.70 |
| Surplus Reserve |
54,640,910.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-730,998,085.64 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
416,173,876.06 |
| Owner's Equity（Stockholder's Equity） |
416,173,876.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,146,573,844.84 |
